-
公开(公告)号:WO2023036350A1
公开(公告)日:2023-03-16
申请号:PCT/CZ2022/050087
申请日:2022-09-09
Inventor: POLASEK, Miloslav , DAVID, Tomas , STRAKA, Michal , JAROS, Adam
IPC: C07D401/14 , A61K49/08 , A61K49/12 , C07D471/22 , C07F9/6524 , C07K7/06 , C07F3/04 , C07F3/06 , C07F3/08 , C07F7/24
Abstract: The present invention relates to compounds of general formula (I) for use as complexing agents. The invention further relates to the coordination compounds thereof, peptide conjugates, method of their preparation and use thereof.
-
公开(公告)号:WO2022247142A1
公开(公告)日:2022-12-01
申请号:PCT/CN2021/127912
申请日:2021-11-01
Applicant: 南方医科大学
Abstract: 本发明公开了一种有机钆纳米粒及其制备方法和应用,所述有机钆纳米粒为亲水性高分子与钆离子结合的粒子,其制备方法为,先使亲水性高分子与钆离子进行配位反应;再加入碱液,反应得到有机钆纳米粒。本发明通过使亲水性高分子与钆离子进行配位反应,将反应体系中的游离钆离子消耗尽,形成亲水性高分子与钆离子结合的粒子;进行配合反应一段时间后再在碱液的作用下加速粒子的生长,得到具有良好T 1成像效果的有机钆纳米粒,所得有机钆纳米粒在1.5T下r 1≥30mM -1s -1,r 2/r 1≤1.3,所得有机钆纳米粒不易解离,克服了氧化钆纳米粒被细胞吞噬后在内涵体或溶酶体的酸性环境下易释放毒性钆离子的缺点。
-
公开(公告)号:WO2022106787A1
公开(公告)日:2022-05-27
申请号:PCT/FR2021/052040
申请日:2021-11-19
Applicant: NH THERAGUIX , UNIVERSITE CLAUDE BERNARD LYON 1 , MEXBRAIN , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - , INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , HOSPICES CIVILS DE LYON , INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Inventor: TILLEMENT, Olivier , LUX, François , VERNOS, Delphine , RODRIGUEZ-LAFRASSE, Claire , BRICHART, Thomas , NATUZZI, Marco , GELOEN, Alain , CHAMPAGNE, Simon , MARTINI, Matteo , ROCCHI, Paul
IPC: A61K47/54 , A61K47/69 , A61K47/59 , A61K41/00 , A61K49/12 , A61P35/00 , A61K49/18 , B82Y15/00 , B82Y5/00 , A61N5/10
Abstract: La présente divulgation porte sur des nanoparticules et leurs utilisations dans le domaine de la médecine, en particulier pour le traitement de tumeurs.
-
4.
公开(公告)号:WO2022023677A1
公开(公告)日:2022-02-03
申请号:PCT/FR2021/051419
申请日:2021-07-29
Applicant: MEXBRAIN , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - , UNIVERSITE CLAUDE BERNARD LYON 1
Inventor: TILLEMENT, Olivier , LUX, François , ROSSETTI, Fabien , NATUZZI, Marco , BRICHART, Thomas , DAVID, Laurent , NUNES DE OLIVEIRA, Paula , MONTEMBAULT, Alexandra
Abstract: L'invention concerne un polysaccharide statistique de masse moléculaire moyenne en poids comprise entre 100kDa et 1000kDa de formule (I) suivante : dans laquelle : chaque Rc représente indépendamment un groupement comportant un agent chélatant, chaque Z représente indépendamment un liant pouvant être une simple liaison ou une chaine hydrocarbonée comportant entre 1 et 12 atomes de carbone, ladite chaine pouvant être linéaire ou ramifiée et pouvant comporter une ou plusieurs insaturations et pouvant comporter un ou plusieurs hétéroatomes, de préférence choisis parmi l'azote, l'oxygène, le soufre et les atomes de la famille des halogènes, x est compris entre 0,005 et 0,7, de préférence entre 0,05 et 0,7, et préférentiellement entre 0,2 et 0,6, y est compris entre 0,01 et 0,7, de préférence entre 0,05 et 0,2, le rapport y/x étant supérieur ou égal à 0,05, de préférence supérieur ou égal à 0,15, et la somme x + y étant supérieure ou égale à 0,30, de préférence supérieure ou égale à 0,35. L'invention a également trait à l'utilisation dudit polysaccharide dans un procédé de dialyse pour la captation d'au moins un métal, dans un procédé d'imagerie IRM., dans un procédé de Curie-thérapie ou dans procédé de marquage anti-contrefaçon de denrées alimentaires.
-
公开(公告)号:WO2021247992A1
公开(公告)日:2021-12-09
申请号:PCT/US2021/035892
申请日:2021-06-04
Applicant: UNIVERSITY OF MARYLAND, BALTIMORE , XUE, Fengtian , WILKS, Angela
Inventor: XUE, Fengtian , WILKS, Angela
Abstract: Gallium-salophen compounds, and methods of using the same for the treatment of disease are disclosed.
-
公开(公告)号:WO2021113829A1
公开(公告)日:2021-06-10
申请号:PCT/US2020/063635
申请日:2020-12-07
Applicant: THE GENERAL HOSPITAL CORPORATION , MATTINGLY, Eli
Inventor: YOO, Byunghee , MEDAROVA, Zdravka O. , YIGIT, Mehmet V.
IPC: A61K49/12 , A61K33/26 , A61K47/36 , G01N33/548
Abstract: The present disclosure presents nanoparticle compositions for use in the treatment, prevention, or imaging of a disease (e.g., cancer), methods of treating, preventing, or imaging a disease in a subject in need thereof with the nanoparticle compositions, and methods of preparing the nanoparticle compositions of the disclosure. The nanoparticle compositions can include a magnetic nanoparticle ferric chloride, ferrous chloride, or a combination thereof, and a dextran coating functionalized with one or more amine groups.
-
7.
公开(公告)号:WO2020123975A1
公开(公告)日:2020-06-18
申请号:PCT/US2019/066280
申请日:2019-12-13
Applicant: THE JOHNS HOPKINS UNIVERSITY
Inventor: POMPER, Martin G. , LESNIAK, Wojciech G. , BOINAPALLY, Srikanth , RAY, Sangeeta Banerjee , FOSS, Cathrine A.
Abstract: Prostate-specific membrane antigen (PSMA)-targeted PAMAM dendrimers (G4-PSMA) and their use for imaging or treating PSMA-expressing tumors or cells are disclosed.
-
公开(公告)号:WO2020107078A1
公开(公告)日:2020-06-04
申请号:PCT/AU2019/051312
申请日:2019-11-29
Applicant: STARPHARMA PTY LTD
Inventor: OWEN, David James , HUFTON, Richard , THURECHT, Kristofer James
IPC: A61K47/60 , A61K47/54 , A61K47/56 , A61K47/62 , A61K47/64 , A61K49/12 , A61K51/06 , C08G83/00 , C08G73/02 , C08L101/00 , A61P35/00 , C07D487/00 , C07D305/14
Abstract: Provided herein is a dendrimer comprising: i) a core unit (C); and ii) building units (BU), wherein the core unit is covalently attached to at least two building units; the dendrimer having from two to six generations of building units; wherein building units of different generations are covalently attached to one another; and the dendrimer further comprising: iii) one or more first terminal groups attached to an outermost building unit, wherein each first terminal group comprises a radionuclide-containing moiety; and iv) one or more second terminal groups attached to an outermost building unit, wherein each second terminal group comprises a pharmacokinetic-modifying moiety; or a salt thereof. Also provided are compositions comprising the dendrimers, and methods of using the dendrimers and compositions in diagnostic and therapeutic applications.
-
9.
公开(公告)号:WO2019190491A1
公开(公告)日:2019-10-03
申请号:PCT/US2018/024681
申请日:2018-03-27
Applicant: NATIONAL HEALTH RESEARCH INSTITUTES , LIN, Wen-Jye , LIN, Shu-Yi
Inventor: LIN, Shu-Yi
Abstract: A sub-nanometer gold sticker for blocking efficiently endotoxin activity to protect against sepsis is disclosed. The sub-nanometer gold sticker comprises a gold nanocluster that serves as a flake-like substrate and a coating of short alkyl motifs that act as an adhesive, allowing the sub-nanometer gold sticker to dock with LPS by compacting the intramolecular hydrocarbon chain-chain distance (d-spacing) of lipid A, an endotoxicity active site that can cause overwhelming cytokine induction resulting in sepsis progression. Methods of blocking endotoxin activity, and suppressing pro-inflammatory cytokines are also disclosed. Also disclosed is a method of protecting against endotoxin-induced sepsis via increasing critical micelle concentration for the inhibition of LPS non-lamellar aggregation.
-
公开(公告)号:WO2019147731A1
公开(公告)日:2019-08-01
申请号:PCT/US2019/014836
申请日:2019-01-23
Applicant: TRUSTEES OF TUFTS COLLEGE
Inventor: GENCO, Caroline, Attardo , PAPADOPOULOS, George
IPC: A61K39/02 , A61K47/54 , A61K47/61 , A61K49/12 , C12N1/20 , C12N1/36 , C07K16/18 , G01N33/53 , G01N33/543
Abstract: A heat killed Porphyromonas gingivalis bacterium expressing a homogenous lipid A structure having a molecular negative mass ion of 1368, 1435/1449, or 1690/1768 is used as an immunomodulator. The immunomodulator may be used in combination with an antigen of interest to potentiate or restrain a host immune response toward the selected antigen.
-
-
-
-
-
-
-
-
-